NCT02104479

Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing

Open Multicenter Diagnostic Study on the Accuracy of Biomarker Testing (Galactomannan (GM), (1-3)-β-D-glucan (BDG), Aspergillus-specific Polymerase Chain Reaction (PCR) Assay) in Pleural Effusion Samples of Immunocompromised Patients With Suspected Invasive Pulmonary Aspergillosis (IPA)

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 200 (estimated)
• Sponsor: Heidelberg University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Diagnostic accuracy of biomarker testing (galactomannan (GM), (1

Detailed description

A multicentre, open, prospective diagnostic study on the diagnostic accuracy of biomarker testing (galactomannan (GM), (1

Conditions

• Invasive Aspergillosis
• Pleural Effusion
• Immunosuppression

Timeline

• Start date: 2014-03-31
• Primary completion: 2020-12-31
• Completion: 2020-12-31
• First posted: 2014-04-04
• Last updated: 2020-04-20

Locations

2 sites across 1 country: Germany